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One of the most widespread clades ofMycobacterium tuberculosisworldwide, the Beijing genotype family, consists of ancient
(atypical) andmodern (typical) strains. Modern Beijing strains outcompete ancient strains in terms of prevalence, while reserv-
ing a higher degree of genetic conservation. We hypothesize that their selective advantage lies in eliciting a different host im-
mune response. Bead-disrupted lysates of a collection of differentM. tuberculosis strains of the modern (n 7) or ancient (n
7) Beijing genotype, as well as the Euro-American lineage (n 6), were used for induction of ex vivo cytokine production in pe-
ripheral bloodmononuclear cells (PBMCs) from 10 healthy individuals. Hierarchical clustering andmultivariate regression
analyses were used to study possible differences in production of nine cytokines. Modern and ancientM. tuberculosis Beijing
genotypes induced different cytokine signatures. Overall induction of interleukin-1 (IL-1), gamma interferon (IFN-), and
IL-22 was 38 to 40% lower after stimulation with modern Beijing strains (corrected P values of<0.0001, 0.0288, and 0.0002, re-
spectively). Euro-American reactivation strains induced 2-fold more TNF- production than both types of Beijing strains. The
observed differences in cytokine induction point to a reduction in proinflammatory cytokine response as a possible contributing
factor to the evolutionary success of modern Beijing strains.
DNA fingerprinting has greatly facilitated the study of the mo-lecular epidemiology of tuberculosis, while disclosing the
phylogeny of the Mycobacterium tuberculosis complex. The first
genotype family described was the Beijing clade (1), later recog-
nized as the most important part of the East Asian lineage (2).
Strains of the widespread Beijing family are of particular interest
due to their established associationwith drug resistance, increased
virulence in animal models, and association with infection of
younger patients (3), the last of which points to an increased rel-
ative reproductive fitness (4).
The vast majority of circulating Beijing strains is thought to
belong to a conserved type genetically, as first described based on
IS6110 restriction fragment length polymorphism (IS6110 RFLP)
analysis (5) and recently confirmed by whole-genome sequencing
(6). These so-called “modern” Beijing strains represent 65 to 95%
of Beijing strains in most areas, including China (7), Russia (8),
Taiwan (9), South Africa (10), Europe (7), and the United States
(11). Modern Beijing strains were first named “typical” by the
presence of a typical pattern of one or two copies of IS6110 in the
NTF chromosomal region. In contrast, this insertionwas found to
be absent in the “atypical” or ancient Beijing strains. These strains
seem in fact to represent a genetically diverse group (6). It is only
in Japan and South Korea that the ancient strains are still highly
prevalent, although they form a declining majority (12, 13).
The high prevalence and degree of genetic conservation of
modern Beijing strains suggest that they possess a selective advan-
tage over ancient Beijing strains and other M. tuberculosis geno-
types. Drug resistance most likely occurred on several indepen-
dent occasions (14) and cannot be linked definitively to one of the
strain subtypes (15, 16).One possible explanation for their success
is that modern Beijing strains induce a different, less effective host
immune response than that with ancient Beijing strains. Although
several studies have reported differences in immune responses
after infection by Beijing genotype strains, none has performed an
extensive comparison of immune responses induced by modern
and ancient Beijing strains. The aim of our study, therefore, was to
examine if the epidemiological success of modernM. tuberculosis
Beijing strains is paralleled by a distinctive cytokine production
profile. Our strain selection comprised a widespread geographic
area and also included Euro-American strains isolated from per-
sons with endogenous reactivation cases in the Netherlands. We
identified differences in innate immune responses between mod-
ern and ancient M. tuberculosis Beijing strains that may help to
explain their evolutionary success.
MATERIALS AND METHODS
Mycobacterium tuberculosis strains. TwentyM. tuberculosis strains were
selected from the reference database of clinical isolates of the Dutch
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Health and Environment Institute (RIVM) in Bilthoven, theNetherlands.
Fourteen had been spoligotyped previously as Beijing strains. Using
IS6110 PCR analysis of the NTF region, these strains were further subdi-
vided intomodern (n 7) and ancient (n 7) Beijing strains (17). A third
group consisted of six strains isolated from elderly (70 years of age)
Dutch tuberculosis (TB) patients. On the basis of IS6110 RFLP typing,
which is applied routinely to all TB cases in the Netherlands, all six had
unique profiles and were assumed to represent endogenous reactivation
from remote infections decades ago. Spoligotyping designated these
strains to the Haarlem and T spoligotypes of the Euro-American lineage
(Fig. 1). All strains were grown inMiddlebrook 7H9medium in one batch
for 3 weeks. Ancient Beijing strains grew to amedian optical density (OD)
of 0.47 (range, 0.32 to 0.61), andmodern Beijing strains grew to amedian
OD of 0.43 (range, 0.32 to 0.57), but the Euro-American reactivation
strains grew less efficiently and reached a median OD of 0.27 (range, 0.15
to 0.55). The strains were washed two times in phosphate-buffered saline
(PBS), heat killed, and then disrupted using a bead beater, after which the
concentration was measured using a bicinchoninic acid (BCA) protein
assay to standardize the concentration used in the immunological exper-
iments.
Stimulation experiment with human PBMCs. Peripheral blood
mononuclear cells (PBMCs) were isolated from buffy coats purchased
from the Sanquin Bloodbank Nijmegen. Healthy volunteers gave their
written informed consent for the use of their blood for scientific purposes,
as approved by the Ethics Committee of Radboud University Medical
Centre, Nijmegen, The Netherlands. Donations occurred anonymously,
and therefore no tuberculosis skin test or gamma interferon (IFN-) re-
lease assay could be performed, but the present incidence of TB in the
indigenous Dutch population is extremely low (4/100,000), andM. bovis
BCG vaccination is not part of the routine vaccination program. Isolation
was performed using Ficoll-Paque, involving separation by a density gra-
dient followed by three wash steps in PBS and resuspension in RPMI 1640
supplemented with Glutamax, pyruvate, and gentamycin. Subsequently,
100 l of PBMCs (5  106/ml) and 50 l of stimulus at 4 times the
designated final concentration were added in duplicate to a 96-well
round-bottom plate, together with 50 l of RPMI, or human pooled se-
rum in case of a 7-day stimulation. Heat-killedCandida hyphae were used
as a positive control. The plates were incubated for 24 h, 48 h, or 7 days at
37°C in a 5%CO2 environment, after which they were spun at 700 g for
8 min. Supernatants were collected and stored at 20°C. Preliminary
studies were performed using twomodern and two ancient strains grown
in different batches to define the dose-response relationship and select the
most appropriate stimulatory concentration of bead-disruptedM. tuber-
culosis, based on the signatures of all cytokines tested. Afterwards, five
experiments, involving two healthy volunteers each, were performedwith
a selection of 20 strains. Enzyme-linked immunosorbent assays (ELISAs)
were performed batchwise following the manufacturer’s protocols for
measuring cytokines in supernatants. The following lengths of stimula-
tion for the different cytokines were based on previous experiments: for
interleukin-1 (IL-1), IL-1 receptor antagonist (IL-1Ra), transforming
growth factor beta (TGF-), tumor necrosis factor alpha (TNF-) (all
from R&D Systems, Minneapolis, MN), and IL-6 (Sanquin, Amsterdam,
theNetherlands), 24 h; for IFN- and IL-10 (Sanquin), 48 h; and for IL-17
and IL-22 (R&D Systems), 7 days.
Data analysis and statistics.Hierarchical clustering analysis was per-
formed to investigate whether modern and ancient Beijing strains in-
duced different cytokine signatures. Data points for 20 strains times 10
donors per cytokine were ln transformed and then normalized by sub-
tracting each value from the mean response per cytokine per donor and
dividing this value by the standard deviation. This resulted in a table with
standardized donor responses per cytokine in rows and different strains in
columns. Using the Pearson correlation, a distance measure was calcu-
lated, on which clustering was performed with the weighted-pair group
method using average linkages (WPGMA) as the linkage method, using
the freeware program J Express 2012 (18).
Multivariate regression on the ln-transformed cytokine data was used
to determine the contributions of individual cytokines to the difference
between the strain groups. In the multivariate regression, groups were
compared based on their genetic classification, unbiased for results of the
clustering hierarchy, to test the hypothesis thatmodern Beijing strains, on
FIG 1 Mycobacterium tuberculosis strains used for this study, with geneticmarkers and countries of origin. IS6110RFLP profiles and clustering are shown, as well
as typing by spoligotyping anddetermination of the presence of IS6110 in theNTF region.Note that all reactivation strainswere isolated fromDutch patients over
70 years of age. n/a, not available.
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average, induced a different immune response. Fixed factors were strain
type (modern Beijing, ancient Beijing, or Euro-American reactivation)
and donor, with the latter used to correct for donor variability. For the
nine cytokines, predicted means for strain types and differences between
those means with respective confidence intervals were calculated with
StataMP, version 12.1.Differences in confidence intervalswere plotted on
a radar graph with a logarithmic axis. Reported P values and confidence
intervals were adjusted by the Bonferroni correction to correct for multi-
ple comparisons. For clarification, relative percentages of differences were
added to the radar graph and, for the reported table values, were trans-
formed as an exponent of e to obtain the prediction of the mean in pg/ml.
RESULTS
Strains.All strains were fully susceptible to all first-line antituber-
culosis drugs. See Fig. 1 for other characteristics. Using a standard-
ized stimulation model with bead-disrupted M. tuberculosis and
isolated PBMCs, we first explored concentrations of 0.1, 1.0, and
10 g/mlM. tuberculosis, looking for a single concentration asso-
ciated with reasonable induction of all cytokines evaluated. We
chose a final concentration of 5 g/ml, as this was expected to
most clearly show differences between groups for all cytokines of
interest. Production of TNF-, IL-1, IL-6, IL-10, IL-17, and
IFN- by PBMCs from 4 donors was almost identical when dif-
ferent concentrations of an H37Rv control strain that was grown
in two different laboratories (the Dutch National TB Reference
Centre and Leiden University Medical Centre) (see Fig. S1 in the
supplemental material) were used.
Cytokine signature. The hierarchical clustering of cytokine
signatures revealed different clusters of strains that grossly fol-
lowed the distinction ofmodern versus ancient Beijing strains and
the Euro-American reactivation strains. This study aimed explic-
itly to explore differences between groups of strains that have
shown important epidemiological differences in terms of recent
spread and genetic heterogeneity. Indeed, the ancient Beijing
strains clustered separately from the epidemiologically more suc-
cessful and genetically more conserved modern Beijing strains. In
the hierarchical clustering, this group of modern Beijing strains
was divided into two groups, one of which also harbored one
Euro-American reactivation strain, while the other Euro-Ameri-
can strains clustered as a fourth cluster (Fig. 2). Multivariate re-
gression was applied to the groups of strains as defined based on
their genetics, and statistically significant differences in cytokine
responses were found betweenmodern Beijing strains and the other
two groups for IL-1, IL-1Ra, IFN-, and IL-22 (Fig. 3A and B).
Individual cytokines. Themost striking difference in cytokine
productionwas observed for induction of IL-1, which is essential
in the protective host defense againstM. tuberculosis (Fig. 3A and
Table 1). Overall, modern Beijing strains induced significantly
lower IL-1 concentrations after 24 h than those of ancient Beijing
strains (estimated means, 3,115 versus 5,184 pg/ml) (P	 0.0001)
and reactivation strains (4,250 pg/ml) (Fig. 3A and B). Moreover,
compared to ancient Beijing strains, modern Beijing strains in-
duced significantly more IL-1Ra (5,094 versus 4,501 pg/ml) (P
0.0001). Because IL-1Ra antagonizes the effect of IL-1, this will
further deplete the biologically active fraction of IL-1 after stim-
ulation with modern Beijing strains. Production of all cytokines,
including IL-1 and IL-1Ra, showed considerable between-strain
FIG 2 Hierarchical clustering of modern and ancient Beijing strains and Euro-American reactivation strains. The figure shows clustering of the virtual distances
between the differentM. tuberculosis strains based on the cytokines they induce in PBMCs. The distance matrix shows similarity (red) and dissimilarity (green)
between cytokine signatures of the respective strains. Analysis was performed on ln-transformed and normalized data with the open source software J Express
(17). See the text for further details.
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and between-donor variability (Fig. 4A). However, at the level of
the individual donors, the amount of IL-1 was consistently
smaller, and that of IL-1Ra was consistently larger, for modern
than for ancient Beijing strains in cells from all 10 donors (Fig. 4B;
see Fig. S4B in the supplemental material).
Modern Beijing strains also induced less production of IFN-
(at 48 h) than that of themore ancient Beijing strains (48 versus 80
pg/ml) (P 0.002). TNF- production at 24 h was slightly lower
for modern than for ancient Beijing strains (300 and 365 pg/ml)
(nonsignificant difference), and interestingly, both groups in-
duced much less TNF- than the Euro-American reactivation
strains did (623 pg/ml) (nonsignificant difference for ancient Bei-
jing strains after the Bonferroni correction; P	 0.0001 for mod-
ern Beijing strains). Production of IL-22 at 7 days was significantly
lower in modern Beijing strains than in ancient Beijing strains
(662 versus 1,061 pg/ml) (P  0.0002). Conversely, induction of
IL-17 at 7 days was higher in modern Beijing strains than in an-
cient Beijing strains (160 pg/ml versus 106 pg/ml) (nonsignificant
difference) and the reactivation strains (103 pg/ml) (P	 0.0001)
(Fig. 3B). No significant differences were found for production of
IL-6 (24 h), TGF- (24 h), and IL-10 (48 h).
DISCUSSION
In our in vitro model, heat-killed and bead-disrupted lysates of
modern (“typical”) M. tuberculosis Beijing strains induced a
clearly different cytokine signature in freshly isolated PBMCs
FIG 3 (A) Differences in cytokine response after stimulation withmodern (red) compared to ancient (blue) Beijing strains. (B) Differences in cytokine response
after stimulationwithmodern (red) and ancient (blue) Beijing strains compared to Euro-American reactivation strains (green). Relative cytokine responses were
calculated bymultivariate regression. The shaded areas show the confidence intervals, which were adjusted by the Bonferroni correction to take into account the
multiple comparisons made. The axis is on the ln scale; corresponding percentages are shown in the legend. A lower response is indicated by projection toward
the center of the figure. Asterisks indicate the significance of the differences, as follows: *, P	 0.05; ***, P	 0.001; ****, P	 0.0001.
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IFN- 48 h 48 (40–57) 80 (67–95) 90 (76–107) 40 0.0288 47 	0.0001 12 1
TNF- 24 h 300 (252–357) 365 (272–490) 623 (535–725) 18 1 52 	0.0001 41 0.3136
IL-1 24 h 3,115 (2,954–3,285) 5,184 (4,823–5,572) 4,250 (4,082–4,424) 40 	0.0001 27 	0.0001 
22 0.0036
IL-1Ra 24 h 5,094 (4,971–5,220) 4,501 (4,329–4,681) 4,531 (4,333–4,738) 
13 0.0001 
12 0.0010 1 1
TGF- 24 h 2,175 (2,067–2,289) 2,264 (2,080–2,465) 2,219 (2,062–2,388) 4 1 2 1 2 1
IL-10 48 h 193 (180–207) 181 (166–198) 201 (181–224) 
6 1 4 1 10 1








IL-22 7 days 662 (618–711) 1,061 (914–1,231) 963 (860–1,079) 38 0.0002 31 	0.0001 
10 1
a Data were calculated by multivariate regression on ln-transformed data. The outcomes were transformed back from ln-transformed data to show predicted means in pg/ml. The
Bonferroni correction was applied to the P values to account for the multiple comparisons made. 95% CI, 95% confidence interval.
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from that of ancient (“atypical”) Beijing strains. Overall, modern
Beijing strains induced considerably less production of IL-1,
IFN-, and IL-22 andmoderately more production of IL-1Ra and
IL-17. Interestingly, stimulationwith Euro-American reactivation
strains from elderly patients resembled stimulation with ancient
Beijing strains, except for the case of TNF-. Euro-American re-
activation strains induced 2-fold more TNF- than both types of
Beijing strains did, whichmay represent a possible explanation for
why infections with these strains appear in such patients only un-
der circumstances of waning immunity.
We hypothesize that the lower levels of induction of pro-
inflammatory cytokines may help to explain the increased spread
of modern Beijing strains across the globe. The presence of an
IS6110 element in the NTF chromosomal region is traditionally
used to distinguish modern from ancient Beijing strains. Dele-
tions that occurred after the insertion of IS6110 are used to further
type the group of modern Beijing strains, but so far, there are
insufficient epidemiological data to define a genetic subgroup
within the modern Beijing strains that is driving their success. For
this reason, we decided to compare the group of modern Beijing
strains as a whole to the other groups.
A striking observation in the present data is that the ancient
Beijing strains, which are considered genetically heterogeneous
(6), showed rather uniform cytokine responses, and also that only
four of seven genetically modern Beijing genotypes showed the
distinctive low inflammatory response. The modern strains that
showed the least induction of proinflammatory cytokines may
share specific properties that enable them to counteract or subvert
effective host responses, and one could thus hypothesize that an
even narrower subgroup within the modern Beijing strains is in
fact responsible for their global emergence. In future epidemio-
logical and experimental studies, mutations and deletions that
occurred subsequent to the insertion of IS6110 into the NTF re-
gion in the evolution of modern Beijing strains will have to be
assessed to define this group more specifically.
Themost striking difference in our study was the almost 2-fold
less IL-1 production induced in PBMCs by modern Beijing
strains than by ancient Beijing strains. For IL-1Ra, the opposite
was found, further limiting the activity of IL-1 after stimulation
withmodernBeijing strains. IL-1 is increasingly recognized as an
important cytokine involved in host defense againstM. tuberculo-
sis. IL-1 restricts mycobacterial growth in murine models, and
IL-1 knockout mice are highly susceptible to mycobacteria. In
humans, polymorphisms in IL-1 or IL-1R are associated with
increased tuberculosis susceptibility and progression (19).
Modern M. tuberculosis Beijing strains also induced less pro-
duction of IFN-, which has a well-established role in protection
against mycobacterial infections, including tuberculosis (20, 21).
Apart from lymphocytes, innate immune cells (NK cells, NK-T
cells, and  T cells) also contribute to the production of IFN- in
response to mycobacteria (19, 22). TNF- production was strik-
ingly lower in response to both types of Beijing strains than in
response to the Euro-American strains isolated frompatients with
reactivation tuberculosis. This is of specific interest because of the
swift reactivation of tuberculosis after TNF--blocking therapy
(23). TNF- has a paramount role in granuloma formation and
maintenance (24) and contributes importantly to the balance of
pro- and anti-inflammatory cytokines that determines the success
of mycobacterial control (25).
IL-17, whichwas induced in larger amounts bymodern Beijing
strains, especially compared to Euro-American reactivation
strains, may act as a double-edged sword: it facilitates the forma-
FIG 4 IL-1 responses of 10 healthy donors to modern and ancient Beijing strains and Euro-American reactivation strains. (A) Strain-associated differences in
cytokine production. (B) Donor-associated differences in cytokine production for modern and ancient Beijing strains, for all 10 donors individually.
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tion of mature granulomas, but in excess it leads to enhanced
neutrophil recruitment and concurrent lung tissue damage (26).
Interestingly, a zebrafish model showed that in the early phase of
granuloma formation, IL-17 also facilitates bacterial spread (27),
whichmakes a high IL-17 concentration possibly favorable to bac-
teria (22). In contrast, IL-22 production was lower in modern
Beijing strains. IL-22 is produced in the lung and has been found
in bronchoalveolar lavage fluid (28). In general, it provides cross
talk between immune cells that produce IL-22 but lack the recep-
tor and nonimmune cells, e.g., lung epithelium cells, that do ex-
press the IL-22 receptor. Activation of the IL-22 receptor on these
cells leads to upregulation of several chemokines in the lung (29).
Lower levels of IL-22, like those found in modern Beijing strains,
might thus lead to less expression of chemokines, possibly favor-
ing outgrowth of M. tuberculosis. However, a definitive role of
IL-22 in human tuberculosis still has to be confirmed: in a mouse
model of tuberculosis, the neutralization of IL-22 did not increase
the bacterial burden in the lungs (26).
In recent years, a number of studies have examinedwhetherM.
tuberculosis strains from different genetic backgrounds induce
strain-specific differences in cytokine production. In the global
phylogeny of M. tuberculosis, evolutionarily modern strains—
bearing the TbD1 deletion, as all Euro-American and Beijing
strains do—generally have a tendency toward inducing a smaller
cytokine response, as recently shown comprehensively in a mac-
rophage infection model by Portevin et al. (30). Other studies,
using small numbers of strains from a wide range of lineages, have
shown the existence of clear but ill-reproducible differences (ex-
tensively reviewed by Coscolla and Gagneux [31]). However, it is
likely thatmost of the evolution ofM. tuberculosisoccurswithin its
main lineages, and our study is the first with a comprehensive
assessment of immune-stimulatory capacity of intralineage
strains. These lineages show a distinctive geographical pattern
(32) andmay adapt to and shape the specific host populations they
encounter.
Few studies have examined cytokine production in multiple
strains within one of the most successful lineages ofM. tuberculo-
sis, the Beijing genotype. Wang et al. found less TNF- induction
for Beijing strains than for H37Rv, with a trend toward lower
TNF- concentrations after stimulation with two ancient Beijing
strains (33). In two macrophage infection models, one Beijing
isolate appeared to bemore immunogenic thanH37Rv,withmore
mRNA expression for IL-1, TNF- (34), and IFN- (35). Krish-
nan et al. found less TNF- induction with the Beijing outbreak
strain HN878 but variable results for other Beijing strains (36).
Kato-Maeda et al. compared Beijing strains with different abilities
to cause secondary disease in humans for their pathogenicity in
guinea pigs. Strains were characterized using genetic regions of
difference. Interestingly, guinea pigs appeared to be most suscep-
tible to ancient Beijing strains (RD207). In line with our study,
the authors of that study found that strains in the modern sublin-
eages RD142 and RD150 induced less TNF-mRNA. Expres-
sion of IFN-mRNA varied among the modern sublineages, and
IL-1 was not measured (37).
To our knowledge, the present study is the first that specifically
examines the successful subbranch of modern strains within M.
tuberculosis Beijing strains. There are, however, a few limitations
to this study. To maximize standardization, we used a model in
which freshly isolated PBMCs were stimulated with heat-killed
and bead-disrupted lysates. Although these lysates, stored inmany
similar aliquots, produce highly reproducible cytokine patterns,
they of course lack some of the lipid structures present in the M.
tuberculosis cell wall. In addition, the use of PBMCs may not fully
reflect the response of resident tissue macrophages, although it is
not logical to expect that the differences in cytokine profiles we
found would be reversed in macrophages, which are related to
circulating monocytes. An alternative approach would have been
to infect macrophages with live mycobacteria. This interesting
model has the disadvantages of less reproducibility and an absence
of lymphocytes. Also, differences in growth kinetics or mycobac-
terial gene expression under specific conditions may themselves
lead to differences in cytokine induction. Yet another model
would be to measure circulating cytokines in patients infected
with different genotype strains, though the possibilities are limited
by differences in disease status; the large variety of genotype
groups, which hinders sound statistical analysis; and the fact that
plasma cytokine concentrations are generally low in tuberculosis
patients. An Ethiopian study designed this way hinted at less in-
duction of IL-4 in patients infected with Euro-American strains
than in those infected with East African-Indian strains (38).
As a strong point, our study design and approach to analyze the
results are thorough and innovative. We used 10 donors and 20
different strains belonging to three subgroups (modern and an-
cient Beijing strains as well as tuberculosis reactivation strains).
This approach provided enough power to detect meaningful dif-
ferences despite variation between donors and different strains
within one subgroup, as was clearly the case for modern Beijing
strains. Hierarchical clustering, which so far has been usedmostly
for gene expression data sets, was used to analyze cytokine signa-
tures. Radar graphs were used to graphically represent cytokine-
specific differences between the three groups of M. tuberculosis
strains.
We conclude that modern Beijing strains show less induction
of IL-1, IFN-, and IL-22 and more induction of IL-1Ra in vitro
compared to ancient Beijing strains and Euro-American reactiva-
tion strains. This differential immune inductionmight contribute
to the epidemiological success of modern M. tuberculosis Beijing
strains.
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